156 related articles for article (PubMed ID: 2537616)
1. Prognostic indicators for failure of surveillance management of stage I non-seminomatous germ cell tumours.
Costello AJ; Mortensen PH; Stillwell RG
Aust N Z J Surg; 1989 Feb; 59(2):119-22. PubMed ID: 2537616
[TBL] [Abstract][Full Text] [Related]
2. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
3. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
[TBL] [Abstract][Full Text] [Related]
4. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
5. Treatment decision for stage I non-seminomatous germ cell tumours based on the risk factor "vascular invasion".
Hoeltl W; Pont J; Kosak D; Honetz N; Marberger M
Br J Urol; 1992 Jan; 69(1):83-7. PubMed ID: 1737260
[TBL] [Abstract][Full Text] [Related]
6. Testicular carcinoma in Denmark 1976-1980. Stage and selected clinical parameters at presentation.
Schultz HP; Arends J; Barlebo H; Brincker H; Strøyer-Christoffersen I; Engelholm SA; Gammelgaard PA; Genster H; Hansen HH; Krag Jacobsen G
Acta Radiol Oncol; 1984; 23(4):249-53. PubMed ID: 6093441
[TBL] [Abstract][Full Text] [Related]
7. Testicular germ cell tumours in Denmark 1976-1980. Pathology of 1058 consecutive cases.
Krag Jacobsen G; Barlebo H; Olsen J; Schultz HP; Starklint H; Søgaard H; Vaeth M
Acta Radiol Oncol; 1984; 23(4):239-47. PubMed ID: 6093440
[TBL] [Abstract][Full Text] [Related]
8. Vascular density does not predict future metastatic disease in clinical stage 1 non-seminomatous germ cell tumours of the testis.
Maher TM; Lee AH
Histopathology; 1998 Mar; 32(3):217-24. PubMed ID: 9568506
[TBL] [Abstract][Full Text] [Related]
9. Histopathological features in stage I non-seminomatous testicular germ cell tumours correlated to relapse. Danish Testicular Cancer Study Group.
Jacobsen GK; Rørth M; Osterlind K; von der Maase H; Jacobsen A; Madsen EL; Pedersen M; Schultz H
APMIS; 1990 Apr; 98(4):377-82. PubMed ID: 2162186
[TBL] [Abstract][Full Text] [Related]
10. Genomic gain and over expression of CCL2 correlate with vascular invasion in stage I non-seminomatous testicular germ-cell tumours.
Gilbert DC; Chandler I; Summersgill B; McIntyre A; Missiaglia E; Goddard NC; Huddart RA; Shipley J
Int J Androl; 2011 Aug; 34(4 Pt 2):e114-21; discussion e121. PubMed ID: 21615418
[TBL] [Abstract][Full Text] [Related]
11. The management of early stage non-seminomatous germ cell tumours of the testis: Edinburgh 1970-1981.
Duncan W; Munro AJ
Br J Urol; 1985 Oct; 57(5):560-6. PubMed ID: 4063737
[TBL] [Abstract][Full Text] [Related]
12. Cancer of the testis: a new paradigm.
Einhorn LH
Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
[No Abstract] [Full Text] [Related]
13. Malignant germ cell tumours in the elderly: a histopathological review of 50 cases in men aged 60 years or over.
Berney DM; Warren AY; Verma M; Kudahetti S; Robson JM; Williams MW; Neal DE; Powles T; Shamash J; Oliver RT
Mod Pathol; 2008 Jan; 21(1):54-9. PubMed ID: 17975539
[TBL] [Abstract][Full Text] [Related]
14. Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse.
Alexandre J; Fizazi K; Mahé C; Culine S; Droz JP; Théodore C; Terrier-Lacombe MJ
Eur J Cancer; 2001 Mar; 37(5):576-82. PubMed ID: 11290432
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of testicular germ cell tumours.
Damjanov I
Eur Urol; 1993; 23(1):2-5; discussion 6-7. PubMed ID: 8386649
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and staging of germ-cell tumours of the testis].
Mottet N; Berger N; Droz JP
Rev Prat; 2007 Feb; 57(4):365-78. PubMed ID: 17455738
[TBL] [Abstract][Full Text] [Related]
18. [Pathologic anatomy of tumors of the testis].
Schill H; Arborio M; Gros P; Grippari JL
Arch Anat Cytol Pathol; 1992; 40(4):195-201. PubMed ID: 1294048
[TBL] [Abstract][Full Text] [Related]
19. [Stage 1 germ-cell tumour].
Faouzi S; Ouguellit S; Loriot Y
Bull Cancer; 2019 Oct; 106(10):887-895. PubMed ID: 31088678
[TBL] [Abstract][Full Text] [Related]
20. Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in "surveillance only" protocols.
Moriyama N; Daly JJ; Keating MA; Lin CW; Prout GR
Cancer; 1985 Nov; 56(10):2492-8. PubMed ID: 2412688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
